Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Primary prevention of cardiovascular disease events in the healthy young population by the PREVENT risk assessment: preliminary results.
Anno:
2025
Background  Cardiovascular diseases (CVD) are the leading cause of global mortality and one of the primary factors contributing to disability.The younger population is often under-represented in CVD studies, although classic CV risk factors such as obesity and unhealthy lifestyles are increasing in this category. The principal aim of the…
Smartwatches in Atrial Fibrillation Detection: Performance Metrics and Clinical Implications
Anno:
2025
Abstract: Smartwatches are becoming pivotal in atrial fibrillation (AF) detection, transforming screening from sporadic tests to continuous monitoring. This review highlights recent data on AF detection accuracy—sensitivity up to 98%—and the potential to expand cardiac care accessibility. We address challenges like false-positive rates and EHR integration, proposing how smartwatches…
Assessment of Cardiovascular System Functional State in Relation to Psychological Stress in Adolescents.
Anno:
2025
A collaborative project between the ABC Study on Heart Disease Foundation and Liceo Guglielmo Marconi. Introduction: Psychological stress is a well-documented risk factor for cardiovascular diseases. Adolescents, undergoing rapid physical and emotional development, are particularly susceptible to stress, making the assessment of its impact on their cardiovascular system crucial….
THE LIPID-LOWERING EFFICACY OF A NUTRACEUTICAL COMBINATION INCLUDING LEUCOSELECT PHYTOSOME, RED RICE, POLICOSANOL AND FOLIC ACID IN DYSLIPIDAEMIA PATIENTS: REAL-WORLD INSIGHTS
Anno:
2025
Background: Cardiovascular disease is a global health concern and reducing plasma LDL-C levels is a major goal in cardiovascular prevention. Our study aimed to evaluate the effectiveness of a nutraceutical formulation including leucoselect® phytosome®, red yeast rice, policosanol and folic acid on LDL-c levels in patients at low cardiovascular risk…
Bridging Gender Gaps in Cardiovascular Risk Management: Evidence for Precision Medicine
Anno:
2025
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, driven largely by modifiable risk factors. However, the impact and management of these risk factors vary significantly between men and women, often to the detriment of female patients. This systematic review explores these disparities, with a focus on innovative…
Gut microbiota and subclinical atherosclerosis: a new emerging perspective.
Anno:
2025
Background Cardiovascular diseases (CVDs) are the leading cause of death in developed countries, significantly affecting quality of life and healthcare costs. While traditional risk factors are well-established, unconventional factors like gut microbiota have gained interest. Understanding the relationship between gut microbiota and cardiovascular events is necessary to enhance current…
Unconventional risk factors in cardiovascular diseases: a population-based Italian cohort study
Anno:
2025
Background Despite significant progress in managing conventional cardiovascular (CV) risk factors, countless CV events still occur in individuals without overt traditional risks. This underscores the need for a more comprehensive understanding of non-traditional risk factors and a more effective integration of risk scoring systems into clinical practice. Methods This…
BEYOND AMYLOIDOSIS: ADDITIONAL FINDINGS FROM THE FIRST SYSTEMATIC CARDIAC SCREENING IN THE ELDERLY
Anno:
2025
Background The CATCH study investigated for the first time the prevalence of cardiac amyloidosis (CA) in an unselected elderly population. General practitioners proposed screening for wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) to all their patients aged 65–90. We sought the following red flags: interventricular septal thickness ≥12 mm, echocardiographic, electrocardiographic…